{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:40:47Z","timestamp":1732030847679},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":323,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Whole tumour cells are a logical basis for generating immunity against the cancers they comprise or represent. A number of human trials have been initiated using cytokine\u2010transfected whole tumour cells of autologous (patient\u2010derived) or allogeneic [major histocompatibility complex (MHC)\u2010disparate] origin as vaccines. Although precedent exists for the efficacy of autologous\u2010transfected cell vaccines in animal models, little preclinical evidence confirms that these findings will extrapolate to allogeneic\u2010transfected cell vaccines. In order to address this issue a murine melanoma cell line (K1735) was transfected to secrete interleukin (IL)\u20102, IL\u20104, IL\u20107 or granulocyte\u2013macrophage colony\u2010stimulating factor (GM\u2010CSF); cytokines currently in use in trials. The efficacy of these cells as irradiated vaccines was tested head\u2010to\u2010head in syngeneic (C3H) mice and in MHC\u2010disparate (C57BL\/6) mice, the former being subsequently challenged with K1735 cells and the latter with naturally cross\u2010reactive B16\u2010F10 melanoma cells. Whilst the GM\u2010CSF\u2010secreting vaccine was the most effective at generating protection in C3H mice, little enhancement in protection above the wild\u2010type vaccine was seen with any of the transfections for the allogeneic vaccines, even though the wild\u2010type vaccine was more effective than the autologous B16\u2010F10 vaccine. Anti\u2010tumour cytotoxic T\u2010lymphocyte (CTL) activity was detected in both models but did not correlate well with protection, whilst <jats:italic>in vitro<\/jats:italic> anti\u2010tumour interferon\u2010\u03b3 (IFN\u2010\u03b3) secretion tended to be higher following the GM\u2010CSF\u2010secreting vaccine. Cytokine transfection of vaccines generally increased anti\u2010tumour CTL activity and IFN\u2010\u03b3 secretion (T helper type 1 response). Further studies in other model systems are required to confirm this apparent lack of benefit of cytokine transduction over wild\u2010type allogeneic vaccines, and to determine which <jats:italic>in vitro<\/jats:italic> assays will correlate best with protection <jats:italic>in vivo<\/jats:italic>.<\/jats:p>","DOI":"10.1046\/j.1365-2567.2001.01176.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:27:59Z","timestamp":1047436079000},"page":"190-198","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines"],"prefix":"10.1111","volume":"102","author":[{"given":"S. M.","family":"Todryk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"Birchall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Erlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Halanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K.","family":"Orleans\u2010Lindsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"5067","article-title":"Protective and curative potential of vaccination with interleukin\u20102\u2010gene\u2010transfected cells from a spontaneous mouse mammary adenocarcinoma","volume":"53","author":"Cavallo F","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1948050"},{"key":"e_1_2_6_4_2","first-page":"6022","article-title":"Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)\u20102, IL\u20104, IL\u20106, IL\u20107, IL\u201010, tumor necrosis factor alpha, granulocyte\u2010macrophage colony\u2010stimulating factor, and gamma\u2010interferon gene or admixed with conventional adjuvants","volume":"54","author":"Allione A","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3539"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7678351"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.769"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4049\/jimmunol.152.5.2324","article-title":"The role of IL\u20102 secreted from genetically modified tumor cells in the establishment of antitumor immunity","volume":"152","author":"Bannerji R","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.143.5.1283"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7513904"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.22.13141"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.317"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950017941"},{"key":"e_1_2_6_14_2","first-page":"1537","article-title":"Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte\u2010macrophage colony\u2010stimulating factor gene transfer","volume":"57","author":"Simons JW","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_15_2","first-page":"5160","article-title":"Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte\u2010macrophage colony\u2010stimulating factor using ex vivo genetransfer","volume":"59","author":"Simons JW","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5699(97)84664-6"},{"key":"e_1_2_6_17_2","first-page":"289","article-title":"The development of therapeutic vaccines for the management of malignant melanoma","volume":"26","author":"Dalgleish AG","year":"1996","journal-title":"Cancer Surv"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199608000-00004"},{"key":"e_1_2_6_19_2","first-page":"3782","article-title":"Protective antitumor immunity induced by immunization with completely allogeneic tumor cells","volume":"56","author":"Toes RE","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300961"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.6-835"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050373"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950016320"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.13-1951"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.9-1303"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80228-8"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.161.6.3033","article-title":"Gene\u2010modified tumor vaccine with therapeutic potential shifts tumor\u2010specific T cell response from a type 2 to a type 1 cytokine profile","volume":"161","author":"Hu HM","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300584"},{"key":"e_1_2_6_29_2","first-page":"2802","article-title":"Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity","volume":"59","author":"Melcher A","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1034"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.10.4645"},{"key":"e_1_2_6_32_2","first-page":"3230","article-title":"Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant","volume":"57","author":"Aruga A","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0598supp-525"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.308"},{"key":"e_1_2_6_35_2","first-page":"853","article-title":"Comparison of IL\u20102\u2010 and IL\u20104\u2010transfected B16\u2013F10 cells with a novel oil\u2010microemulsion adjuvant for B16\u2013F10 whole cell tumour vaccine","volume":"3","author":"Souberbielle BE","year":"1996","journal-title":"Gene Ther"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.2001.01176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.2001.01176.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.2001.01176.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T16:58:53Z","timestamp":1697648333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.2001.01176.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1046\/j.1365-2567.2001.01176.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.2001.01176.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2001-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}